Angiogenesis


During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
A8668 Thrombin Receptor Agonist PeptideSummary: Protease-activated receptor agonist -
A8669 AC 55541Target: PARSummary: PAR2 agonist,potent and selective -
A8670 AC 264613Summary: PAR2 agonist,potent and selective -
A8671 VKGILS-NH2Summary: control peptide for SLIGKV-NH2, PAR1 agonist -
A8672 RLLFT-NH2Summary: Protease-activated receptor agonist -
A8673 LRGILS-NH2Summary: Protease-activated receptor agonist -
A8675 TRAP-6Target: PARSummary: PAR1 agonist -
A8676 2-Furoyl-LIGRLO-amideSummary: Protease-activated receptor agonist -
A8677 SLIGKV-NH2Summary: PAR2 agonist -
B1408 CNX-774Summary: BTK inhibitor, orally active, irreversible and selective

